The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
DRI Dietary Reference Intakes: For Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline
Miettinen TA, Taskinen M-R, Pelkonen R, Nikkila EA. 1969. Glucose tolerance and plasma insulin in man during acute and chronic administration of nicotinic acid. Acta Med Scand 186:247–253.
Millay RH, Klein ML, Illingworth DR. 1988. Niacin maculopathy. Ophthalmology 95:930–936.
Miller DR, Hayes KC. 1982. Vitamin excess and toxicity. In: Hathcock JN, ed. Nutritional Toxicology, Vol. 1. New York: Academic Press. Pp. 81–133.
Montalto MB, Benson JD, Martinez GA. 1985. Nutrient intake of formula-fed infants and infants fed cow’s milk. Pediatrics 75:343–351.
Morrow JD, Parsons WG 3rd, Roberts LJ 2nd. 1989. Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid. Prostaglandins 38:263–274.
Morrow JD, Awad JA, Oates JA, Roberts LJ. 1992. Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans. J Invest Dermatol 98:812–815.
Moss AJ, Levy AS, Kim I, Park YK. 1989. Use of Vitamin and Mineral Supplements in the United States: Current Users, Types of Products, and Nutrients. Advance Data, Vital and Health Statistics of the National Center for Health Statistics, No. 174. Hyattsville, MD: National Center for Health Statistics.
Mrochek JE, Jolley RL, Young DS, Turner WJ. 1976. Metabolic response of humans to ingestion of nicotinic acid and nicotinamide. Clin Chem 22:1821–1827.
Mullin GE, Greenson JK, Mitchel MC. 1989. Fulminant hepatic failure after ingestion of sustained-release nicotinic acid. Ann Intern Med 111:253–255.
NRC (National Research Council). 1989. Recommended Dietary Allowances, 10th ed. Washington, DC: National Academy Press.
Palumbo PJ. 1991. Rediscovery of crystalline niacin. Mayo Clin Proc 66:112–113.
Pardue WO. 1961. Severe liver dysfunction during nicotinic acid therapy. J Am Med Assoc 175:137–138.
Patterson JI, Brown RR, Linkswiler H, Harper AE. 1980. Excretion of tryptophanniacin metabolites by young men: Effects of tryptophan, leucine, and vitamin B6 intakes. Am J Clin Nutr 33:2157–2167.
Patterson DJ, Dew EW, Gyorkey R, Graham GY. 1983. Niacin hepatitis. South Med J 76:239–241.
Rader JI, Calvert RJ, Hathcock JN. 1992. Hepatic toxicity of unmodified and time-release preparations of niacin. Am J Med 92:77–81.
Ribaya-Mercado JD, Russell RM, Rasmussen HM, Grim MC, Perrone-Petty G, Gershoff SN. 1997. Effect of niacin status on gastrointestinal function and serum lipids. FASEB J 11:A179.
Rivin AU. 1959. Jaundice occurring during nicotinic acid therapy for hypercholesteremia. J Am Med Assoc 170:2088–2089.
Rose DP, Braidman IP. 1971. Excretion of tryptophan metabolites as affected by pregnancy, contraceptive steroids, and steroid hormones. Am J Clin Nutr 24:673–683.
Sauberlich HE, Skala JH, Dowdy RP. 1974. Laboratory Tests for the Assessment of Nutritional Status. Boca Raton, FL: CRC Press.
Schwartz ML. 1993. Severe reversible hyperglycemia as a consequence of niacin therapy. Arch Intern Med 153:2050–2052.
Sebrell WH, Butler RE. 1938. A reaction to the oral administration of nicotinic acid. J Am Med Assoc 111:2286–2287.